Cardiac Implantable Electronic Devices in the Fontan Patient
Tài liệu tham khảo
Khairy, 2007, Univentricular heart, Circulation, 115, 800, 10.1161/CIRCULATIONAHA.105.592378
Hoffman, 2002, The incidence of congenital heart disease, J Am Coll Cardiol, 39, 1890, 10.1016/S0735-1097(02)01886-7
Rao, 2000, Tricuspid atresia, Curr Treat Options Cardiovasc Med, 2, 507, 10.1007/s11936-000-0046-6
Fontan, 1971, Surgical repair of tricuspid atresia, Thorax, 26, 240, 10.1136/thx.26.3.240
Rychik, 2019, Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association, Circulation, 140, e234, 10.1161/CIR.0000000000000696
Backer, 2011, Extracardiac versus intra-atrial lateral tunnel Fontan: extracardiac is better, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 14, 4, 10.1053/j.pcsu.2011.01.019
de Leval, 2005, The Fontan circulation: a challenge to William Harvey?, Nat Clin Pract Cardiovasc Med, 2, 202, 10.1038/ncpcardio0157
Del Duca, 2012, Hypoxia in early life is associated with lasting changes in left ventricular structure and function at maturity in the rat, Int J Cardiol, 156, 165, 10.1016/j.ijcard.2010.10.135
Dahlqvist, 2012, Heart rate variability in children with Fontan circulation: lateral tunnel and extracardiac conduit, Pediatr Cardiol, 33, 307, 10.1007/s00246-011-0126-2
Jonas, 2011, The intra/extracardiac conduit fenestrated fontan, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, 14, 11, 10.1053/j.pcsu.2011.01.010
Zhao, 2009, Relationship between autonomic innervation in crista terminalis and atrial arrhythmia, J Cardiovasc Electrophysiol, 20, 551, 10.1111/j.1540-8167.2008.01392.x
Schwartz, 2018, Late outcomes after the Fontan procedure in patients with single ventricle: a meta-analysis, Heart, 104, 1508, 10.1136/heartjnl-2017-312807
Dahlqvist, 2019, Pacemaker treatment after Fontan surgery: a Swedish national study, Congenit Heart Dis, 14, 582, 10.1111/chd.12766
Momma, 1990, Characteristics and natural history of abnormal atrial rhythms in left isomerism, Am J Cardiol, 65, 231, 10.1016/0002-9149(90)90090-N
Dahlqvist, 2019, Sinus node dysfunction in patients with Fontan circulation: could heart rate variability be a predictor for pacemaker implantation?, Pediatr Cardiol, 40, 685, 10.1007/s00246-019-02092-5
Alnoor, 2021, Hemodynamic impact of atrial pacing in patients with Fontan physiology and junctional rhythm: a cardiac catheterization study, Pediatr Cardiol, 43, 508, 10.1007/s00246-021-02747-2
Song, 2015, Intra-atrial reentrant tachycardia in adult patients after Fontan operation, Int J Cardiol, 187, 157, 10.1016/j.ijcard.2015.03.157
Verheugt, 2010, Mortality in adult congenital heart disease, Eur Heart J, 31, 1220, 10.1093/eurheartj/ehq032
Escudero, 2013, Electrophysiologic considerations in congenital heart disease and their relationship to heart failure, Can J Cardiol, 29, 821, 10.1016/j.cjca.2013.02.016
Khairy, 2014, Heart Rhythm, 11, e102, 10.1016/j.hrthm.2014.05.009
Kramer, 2018, Safety and efficacy of atrial antitachycardia pacing in congenital heart disease, Heart Rhythm, 15, 543, 10.1016/j.hrthm.2017.12.016
Drago, 2006, Long term management of atrial arrhythmias in young patients with sick sinus syndrome undergoing early operation to correct congenital heart disease, Europace, 8, 488, 10.1093/europace/eul069
Khairy, 2006, Transvenous pacing leads and systemic thromboemboli in patients with intracardiac shunts: a multicenter study, Circulation, 113, 2391, 10.1161/CIRCULATIONAHA.106.622076
Assaad, 2021, Atrial pacing in Fontan patients: the effect of transvenous lead on clot burden, Heart Rhythm, 18, 1860, 10.1016/j.hrthm.2021.06.1191
Marinelli, 2020, Intra-atrial block requiring dual-site atrial pacing through a femoral approach in a univentricular heart, HeartRhythm Case Rep, 6, 390, 10.1016/j.hrcr.2020.03.009
Rosenthal, 2014, Transvenous atrial pacing from the superior vena cava stump after the hemi-Fontan operation: a new approach, Pacing Clin Electrophysiol, 37, 531, 10.1111/pace.12305
Moore, 2014, Transpulmonary atrial pacing: an approach to transvenous pacemaker implantation after extracardiac conduit Fontan surgery, J Cardiovasc Electrophysiol, 25, 1028, 10.1111/jce.12447
Arif, 2016, Permanent trans-venous pacing in an extra-cardiac Fontan circulation, Europace, 18, 304, 10.1093/europace/euv110
Umamaheshwar, 2019, Endocardial transvenous pacing in patients with surgically palliated univentricular hearts: a review on different techniques, problems and management, Indian Pacing Electrophysiol J, 19, 15, 10.1016/j.ipej.2018.11.013
Hoyt, 2022, Epicardial atrial pacing after the extracardiac Fontan operation: feasibility of an entirely transvenous approach, J Cardiovasc Electrophysiol, 33, 128, 10.1111/jce.15285
Harake, 2018, Transvenous pacemaker implantation after the bidirectional Glenn operation for patients with complex congenital disease, J Cardiovasc Electrophysiol, 29, 497, 10.1111/jce.13404
Bharati, 1975, The course of the conduction system in single ventricle with inverted (L-) loop and inverted (L-) transposition, Circulation, 51, 723, 10.1161/01.CIR.51.4.723
Shaher, 1963, The electrocardiogram in single ventricle, Br Heart J, 25, 465, 10.1136/hrt.25.4.465
Marshall, 2016, A review of surgical atrioventricular block with emphasis in patients with single ventricle physiology, Congenit Heart Dis, 11, 462, 10.1111/chd.12372
D'Ercole, 2018, Paravertebral block for thoracic surgery, J Cardiothorac Vasc Anesth, 32, 915, 10.1053/j.jvca.2017.10.003
Gupta, 2012, A novel approach to eliminate intraventricular lead placement in patients with congenital heart disease, J Interv Card Electrophysiol, 35, 115, 10.1007/s10840-012-9682-5
Egbe, 2017, Outcomes of cardiac pacing in adult patients after a Fontan operation, Am Heart J, 194, 92, 10.1016/j.ahj.2017.08.019
Bowman, 2021, Cardiac implantable device outcomes and lead survival in adult congenital heart disease, Int J Cardiol, 324, 52, 10.1016/j.ijcard.2020.09.027
McLeod, 2010, Epicardial versus endocardial permanent pacing in adults with congenital heart disease, J Interv Card Electrophysiol, 28, 235, 10.1007/s10840-010-9494-4
Bulic, 2017, Ventricular pacing in single ventricles: a bad combination, Heart Rhythm, 14, 853, 10.1016/j.hrthm.2017.03.035
Poh, 2019, Pacemakers are associated with a higher risk of late death and transplantation in the Fontan population, Int J Cardiol, 282, 33, 10.1016/j.ijcard.2019.01.088
Fishberger, 1996, Long-term outcome in patients with pacemakers following the Fontan operation, Am J Cardiol, 77, 887, 10.1016/S0002-9149(97)89191-6
Kodama, 2019, Outcome of patients with functional single ventricular heart after pacemaker implantation: what makes it poor, and what can we do?, Heart Rhythm, 16, 1870, 10.1016/j.hrthm.2019.06.019
Dubin, 2005, Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study, J Am Coll Cardiol, 46, 2277, 10.1016/j.jacc.2005.05.096
Cecchin, 2009, Cardiac resynchronization therapy (and multisite pacing) in pediatrics and congenital heart disease: five years experience in a single institution, J Cardiovasc Electrophysiol, 20, 58, 10.1111/j.1540-8167.2008.01274.x
O'Leary, 2018, Dual-site ventricular pacing in patients with Fontan physiology and heart block: does it mitigate the detrimental effects of single-site ventricular pacing?, JACC Clin Electrophysiol, 4, 1289, 10.1016/j.jacep.2018.07.004
Joyce, 2020, Cardiac resynchronization therapy improves the ventricular function of patients with Fontan physiology, Am Heart J, 230, 82, 10.1016/j.ahj.2020.09.018
Janousek, 2013, Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study, Circulation, 127, 613, 10.1161/CIRCULATIONAHA.112.115428
Motonaga, 2012, Insights into dyssynchrony in hypoplastic left heart syndrome, Heart Rhythm, 9, 2010, 10.1016/j.hrthm.2012.08.031
Strauss, 2012, Differentiation between left bundle branch block and left ventricular hypertrophy: implications for cardiac resynchronization therapy, J Electrocardiol, 45, 635, 10.1016/j.jelectrocard.2012.09.001
Rosner, 2018, Classic-pattern dyssynchrony in adolescents and adults with a Fontan circulation, J Am Soc Echocardiogr, 31, 211, 10.1016/j.echo.2017.10.018
Khairy, 2008, Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery, Circulation, 117, 85, 10.1161/CIRCULATIONAHA.107.738559
Poh, 2020, Modes of late mortality in patients with a Fontan circulation, Heart, 106, 1427, 10.1136/heartjnl-2019-315862
Pundi, 2017, Sudden cardiac death and late arrhythmias after the Fontan operation, Congenit Heart Dis, 12, 17, 10.1111/chd.12401
Rathod, 2010, Myocardial fibrosis identified by cardiac magnetic resonance late gadolinium enhancement is associated with adverse ventricular mechanics and ventricular tachycardia late after Fontan operation, J Am Coll Cardiol, 55, 1721, 10.1016/j.jacc.2009.12.036
Dodeja, 2019, Detection of arrhythmias in adult congenital heart disease patients with LINQTM implantable loop recorder, Congenit Heart Dis, 14, 745, 10.1111/chd.12815
Tonko, 2021, Completely epicardial implantable cardioverter/defibrillator (ICD) and CRT-D systems: a case series and systematic literature review, Pacing Clin Electrophysiol, 44, 1616, 10.1111/pace.14318
Aleksic, 2007, The innominate vein as alternative venous access for complicated implantable cardioverter defibrillator revisions, Pacing Clin Electrophysiol, 30, 957, 10.1111/j.1540-8159.2007.00792.x
Bhakta, 2010, Nontraditional implantable cardioverter defibrillator placement in adult patients with limited venous access: a case series, Pacing Clin Electrophysiol, 33, 217, 10.1111/j.1540-8159.2009.02577.x
Jaroszewski, 2009, Nontraditional surgical approaches for implantation of pacemaker and cardioverter defibrillator systems in patients with limited venous access, Ann Thorac Surg, 88, 112, 10.1016/j.athoracsur.2009.04.006
Nery, 2013, Implantable cardioverter-defibrillator insertion in congenital heart disease without transvenous access to the heart, Can J Cardiol, 29, 10.1016/j.cjca.2012.04.020
Padanilam, 2021, Novel approach to intracardiac defibrillator placement in patients with atriopulmonary Fontan: ventricular defibrillation with an atrial positioned ICD lead, J Cardiovasc Electrophysiol, 32, 3275, 10.1111/jce.15265
Cannon, 2006, Innovative techniques for placement of implantable cardioverter-defibrillator leads in patients with limited venous access to the heart, Pacing Clin Electrophysiol, 29, 181, 10.1111/j.1540-8159.2006.00314.x
Krause, 2019, Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?, Europace, 21, 106, 10.1093/europace/euy219
Bardy, 2010, An entirely subcutaneousimplantable cardioverter-defibrillator, N Engl J Med, 363, 36, 10.1056/NEJMoa0909545
Burke, 2015, Safety and efficacy of the totally subcutaneous implantable defibrillator: 2-year results from a pooled analysis of the IDE study and EFFORTLESS registry, J Am Coll Cardiol, 65, 1605, 10.1016/j.jacc.2015.02.047
Knops, 2020, PRAETORIAN Investigators. Subcutaneous or transvenous defibrillator therapy, N Engl J Med, 383, 526, 10.1056/NEJMoa1915932
Zeb, 2015, Potential eligibility of congenital heart disease patients for subcutaneous implantable cardioverter-defibrillator based on surface electrocardiogram mapping, Europace, 17, 1059, 10.1093/europace/euu375
Garside, 2019, Eligibility for subcutaneous implantable cardioverter defibrillators in the adult congenital heart disease population, Pacing Clin Electrophysiol, 42, 65, 10.1111/pace.13537
Wang, 2020, Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease, Heart Rhythm, 17, 860, 10.1016/j.hrthm.2020.01.016
Zormpas, 2021, Eligibility for subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease, ESC Heart Fail, 8, 1502, 10.1002/ehf2.13243
Moore, 2016, Alliance for Adult Research in Congenital Cardiology (AARCC). Clinical experience with the subcutaneous implantable cardioverter-defibrillator in adults with congenital heart disease, Circ Arrhythm Electrophysiol, 9, 10.1161/CIRCEP.116.004338
D'Souza, 2016, Outcomes in patients with congenital heart disease receiving the subcutaneous implantable-cardioverter defibrillator: results from a pooled analysis from the IDE study and the EFFORTLESS S-ICD registry, JACC Clin Electrophysiol, 2, 615, 10.1016/j.jacep.2016.02.008
Huang, 2016, concomitant use of the subcutaneous implantable cardioverter defibrillator and a permanent pacemaker, Pacing Clin Electrophysiol, 39, 1240, 10.1111/pace.12955
Paterson, 2021, 2021 update on safety of magnetic resonance imaging: joint statement from Canadian Cardiovascular Society/Canadian Society for Cardiovascular Magnetic Resonance/Canadian Heart Rhythm Society, Can J Cardiol, 37, 835, 10.1016/j.cjca.2021.02.012
Balmer, 2019, Magnetic resonance imaging of patients with epicardial leads: in vitro evaluation of temperature changes at the lead tip, J Interv Card Electrophysiol, 56, 321, 10.1007/s10840-019-00627-7
Vuorinen, 2022, Magnetic resonance imaging safety in patients with abandoned or functioning epicardial pacing leads, Eur Radiol, 32, 3830, 10.1007/s00330-021-08469-6
Bireley, 2020, Cardiac magnetic resonance imaging (MRI) in children is safe with most pacemaker systems, including those with epicardial leads, Pediatr Cardiol, 41, 801, 10.1007/s00246-020-02316-z
Gakenheimer-Smith, 2020, MRI in pediatric and congenital heart disease patients with CIEDs and epicardial or abandoned leads, Pacing Clin Electrophysiol, 43, 797, 10.1111/pace.13984
Vatterott, 2021, Implant, performance, and retrieval of an atrial leadless pacemaker in sheep, Heart Rhythm, 18, 288, 10.1016/j.hrthm.2020.09.022
Okabe, 2022, Leadless left ventricular stimulation with WiSE-CRT System: initial experience and results from phase I of SOLVE-CRT study (nonrandomized, roll-in phase), Heart Rhythm, 19, 22, 10.1016/j.hrthm.2021.06.1195